Status:
COMPLETED
Medication Adherence Therapy for Opioid Abusing Pain Patients
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Pain
Chronic Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medica...
Detailed Description
Project Pain is a Stage I behavioral therapies development project aimed at developing and pilot testing a novel intervention for patients with chronic non-malignant pain who have experienced difficul...
Eligibility Criteria
Inclusion
- Uninterrupted pain of at least 6 months duration
- Pain is continuous, rather than intermittent
- Pain in the severe range (VAS = 7-10) while medicated
- Poor response to non-pharmacological interventions for pain (if appropriate)
- One or more of the following pain diagnoses: (a) back/neck pain; (b) myofacial pain; (c) neuropathic pain (e.g., diabetic or AIDS neuropathy, Complex regional pain syndrome); (d) arthritic pain; (e) MS; or (f) sickle cell (must meet chronicity criteria)
- Evidence of tolerance/physiological dependence on opioid analgesics
- Current opioid use disorder (DSM-IV criteria)
- Continuous use of opioid analgesics for a minimum of 6 months prior to referral. \[Note: This is consistent with minimum 6-month requirement for diagnosis of chronic pain\].
- Minimum of 2 signs/symptoms of medication mismanagement identified by the Referring MD (PROBLEMS WITH PAIN MEDS checklist)
Exclusion
- Please contact site regarding exclusion criteria for this study.
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00249587
Start Date
September 1 2000
End Date
September 1 2005
Last Update
January 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Behavioral Science Research Unit
New York, New York, United States, 10025